Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity.

Wang J, Lu D, Yu X, Qi X, Lin H, Holloman BL, Jin F, Xu L, Ding L, Peng W, Wang M, Chen X
Res Sq [Preprint]. 2024 Apr 8:rs.3.rs-4156736. doi: 10.21203/rs.3.rs-4156736/v1. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.